Keros Therapeutics, Inc 10-K for FY2024
Keros Therapeutics, Inc. (KROS)
10-K
2025-02-26
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Keros Therapeutics, Inc filed this 10-K on February 26, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.55M
- up 2251.0% from $151K a year earlier
- Net loss
- $187.35M
- compared with a net loss of $152.99M a year earlier
- Diluted EPS
- -$5.00
- compared with -$5.20 a year earlier